Rothschild Investment LLC’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.28K Buy
196
+30
+18% +$428 ﹤0.01% 2702
2026
Q1
$2.79K Hold
166
– – ﹤0.01% 2379
2025
Q4
$2.66K Buy
166
+21
+14% +$313 ﹤0.01% 2216
2025
Q3
$1.79K Sell
145
-15
-9% -$176 ﹤0.01% 2299
2025
Q2
$1.84K Sell
160
-85
-35% -$1.01K ﹤0.01% 2139
2025
Q1
$3.67K Buy
245
+75
+44% +$1.26K ﹤0.01% 1581
2024
Q4
$2.94K Hold
170
– – ﹤0.01% 1579
2024
Q3
$3.15K Buy
170
+50
+42% +$1K ﹤0.01% 1482
2024
Q2
$2.44K Buy
120
+10
+9% +$177 ﹤0.01% 1336
2024
Q1
$1.88K Buy
110
+10
+10% +$157 ﹤0.01% 1218
2023
Q4
$1.77K Buy
+100
New +$2.02K ﹤0.01% 1159

Other funds holding CLB

Rothschild Investment LLC's CLB Position: Q2 2026 in Review

Rothschild Investment LLC increased its Core Laboratories (CLB) stake by 18% in Q2 2026, buying an estimated $428 and bringing the position to 196 shares worth $2.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2702.

Rothschild Investment LLC first reported a position in CLB in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.67K in Q1 2025. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Rothschild Investment LLC held 196 shares of Core Laboratories worth $2.28K as of Q2 2026.
  • Rothschild Investment LLC bought 30 Core Laboratories shares in Q2 2026, an estimated $428.
  • Core Laboratories made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2702 holding.
  • Rothschild Investment LLC first reported a position in Core Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Rothschild Investment LLC's Core Laboratories position peaked at $3.67K in Q1 2025.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.